<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04672122</url>
  </required_header>
  <id_info>
    <org_study_id>MU-CIRB2020/314.0210</org_study_id>
    <nct_id>NCT04672122</nct_id>
  </id_info>
  <brief_title>The Effects of Cathodal tDCS on Muscle Strength in Healthy Adults</brief_title>
  <official_title>The Effects of Cathodal tDCS on Muscle Strength in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effects of different intensity of cathodal tDCS on muscle strength in&#xD;
      healthy adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique&#xD;
      that can modulate cortical excitability. In 2000, Nitsche and Paulus reported the&#xD;
      polarity-dependent effect of tDCS in humans, i.e., anodal tDCS facilitates cortical&#xD;
      excitability while cathodal tDCS decreases it. (Nitsche &amp; Paulus, 2000). TDCS studies have&#xD;
      been replicated by many researchers and reported similar effects of tDCS in humans when using&#xD;
      anodal and cathodal tDCS with an intensity of 1 mA. The linear effect of tDCS also has been&#xD;
      reported by various studies, i.e., when increase intensity, the polarity-dependent effect of&#xD;
      tDCS also enhances. However, conflicting results of cathodal tDCS efficacy have been&#xD;
      reported.&#xD;
&#xD;
      Cortical excitability has been used to represent the efficacy of tDCS on neuroplasticity. The&#xD;
      linear effect of cathodal tDCS on cortical excitability have been reported by researchers&#xD;
      when using intensities at 1, 2, and 3 mA stimulated at the primary motor cortex in healthy&#xD;
      participants (Batsikadze et al., 2013; Jamil et al., 2017; Kuo et al., 2013; Mosayebi Samani&#xD;
      et al., 2019; Nitsche et al., 2003). Nevertheless, some studies showed the non-linear effects&#xD;
      of cathodal tDCS (i.e., when increases intensity, cathodal tDCS enhances the cortical&#xD;
      excitability) when using intensities at 1.5 and 2 mA in healthy participants (Batsikadze et&#xD;
      al., 2013; Jamil et al., 2017; Mosayebi Samani et al., 2019). Hence, cathodal tDCS efficacy&#xD;
      on cortical excitability is still controversy.&#xD;
&#xD;
      Muscle performance is an outcome that represents clinical change induced by tDCS. Previous&#xD;
      studies reported the tendency of cathodal tDCS efficacy in decreasing muscle performance of&#xD;
      both upper and lower extremities in healthy participants (Cogiamanian et al., 2007; Tanaka et&#xD;
      al., 2009). However, previous studies used a single intensity of tDCS in each study. Hence,&#xD;
      there was no direct comparison between different intensities of cathodal tDCS on muscle&#xD;
      performance in healthy participants.&#xD;
&#xD;
      In our study, we aim to investigate the effect of different intensities of cathodal tDCS on&#xD;
      muscle strength in healthy participants.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 16, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline muscle strength after tDCS</measure>
    <time_frame>Baseline (Pretest) and 40 minutes ( posttest)</time_frame>
    <description>Muscle strength will be measured in Newton by using a hand-held dynamometer.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Healthy Participants</condition>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham transcranial direct current stimulation (tDCS) will be applied for 20 mins. Cathode on the primary motor area (M1) and Anode on the supraorbital area of contralateral side. Current intensity will be at 2 mA (sham mode). The scope of intervention is to investigate effect of sham tDCS on muscle strength.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cathodal-tDCS 1 mA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cathodal transcranial direct current stimulation (tDCS) will be applied for 20 mins. Cathode on the primary motor area (M1) and Anode on the supraorbital area of contralateral side. Current intensity is fixed at 1 mA and current will flow continuously. The scope of intervention is to investigate effect of cathodal tDCS on muscle strength.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cathodal-tDCS 1.5 mA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cathodal transcranial direct current stimulation (tDCS) will be applied for 20 mins. Cathode on the primary motor area (M1) and Anode on the supraorbital area of contralateral side. Current intensity is fixed at 1.5 mA and current will flow continuously. The scope of intervention is to investigate effect of cathodal tDCS on muscle strength.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cathodal-tDCS 2 mA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cathodal transcranial direct current stimulation (tDCS) will be applied for 20 mins. Cathode on the primary motor area (M1) and Anode on the supraorbital area of contralateral side. Current intensity is fixed at 2 mA and current will flow continuously. The scope of intervention is to investigate effect of cathodal tDCS on muscle strength.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial direct current stimulation</intervention_name>
    <description>Cathodal tDCS will be applied for 20 mins.</description>
    <arm_group_label>Cathodal-tDCS 1 mA</arm_group_label>
    <arm_group_label>Cathodal-tDCS 1.5 mA</arm_group_label>
    <arm_group_label>Cathodal-tDCS 2 mA</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male and female healthy adults&#xD;
&#xD;
          2. Age range between 18 - 60 years old&#xD;
&#xD;
          3. Right-handed dominant identified by the Edinburg Handedness Inventory&#xD;
&#xD;
          4. No recent muscle injuries of both limbs for a past 6-months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Consumed caffeine within 24 hours prior the experiment&#xD;
&#xD;
          2. History of neurological symptoms i.e. seizures, weakness, loss of sensation or unclear&#xD;
             history of pass illness&#xD;
&#xD;
          3. Presence of metal implantation, intracranial shunt, cochlear implantation or cardiac&#xD;
             pacemakers&#xD;
&#xD;
          4. Presence of opened wound or infectious wound around scalp&#xD;
&#xD;
          5. Presence of pain in evaluating muscle groups&#xD;
&#xD;
          6. History of surgery in evaluating limbs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wanalee Klomjai, PhD</last_name>
    <role>Study Director</role>
    <affiliation>MU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wanalee Klomjai, PhD</last_name>
    <phone>+6624415450</phone>
    <phone_ext>20216</phone_ext>
    <email>wanalee.klo@mahidol.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Physical Therapy, Mahidol University</name>
      <address>
        <city>Salaya</city>
        <state>Nakhon Pathom</state>
        <zip>73170</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanalee Klomjai, PhD</last_name>
      <phone>+6624415450</phone>
      <phone_ext>20216</phone_ext>
      <email>wanalee.klo@mahidol.edu</email>
    </contact>
    <investigator>
      <last_name>Wanalee Klomjai, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benchaporn Aneksan, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oranich Vimolratana, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 9, 2020</study_first_submitted>
  <study_first_submitted_qc>December 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

